Hospital
Portercare Adventist Health System
Portercare Adventist Health System was paid $1.24M by Medicaid between Jan 2018 and Dec 2024, across 53 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoPORTERCARE ADVENTIST HEALTH SYSTEM
PARKER, CO 80138
PARKER, CO 80138
33aNPI1386651297assigned 08/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.24M
24GClaims39,293
24DCodes billed53
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Colorado
Rank by total paid#26 of 51
Median peer was paid$1.24M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,045 | $135K | |
| 2019 | 4,611 | $95K | |
| 2020 | 4,420 | $110K | |
| 2021 | 5,860 | $169K | |
| 2022 | 5,953 | $277K | |
| 2023 | 8,611 | $364K | |
| 2024incomplete | 2,793 | $91K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 3,639 | 3,305 | $406K |
| 96361 | Intravenous infusion, hydration; each additional hour | 26% | 1,561 | 1,359 | $328K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 1,905 | 1,730 | $204K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.8% | 1,055 | 930 | $109K |
| 80053 | Comprehensive metabolic panel | 6.2% | 6,209 | 5,505 | $77K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.6% | 1,062 | 1,026 | $69K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 150 | 143 | $10K |
| 0002A | <1% | 89 | 82 | $5K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,678 | 2,400 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 39 | 25 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 31 | 25 | $4K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 42 | 39 | $3K |
41 more codes
| 0001A | <1% | 74 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 151 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 16 | $1K |
| 84484 | <1% | 64 | $991.55 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 17 | $976.36 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,285 | $972.05 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 756 | $967.40 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,412 | $934.70 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 388 | $701.61 |
| 83605 | <1% | 18 | $530.98 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 39 | $353.41 |
| 82728 | <1% | 12 | $353.40 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 12 | $284.46 |
| 80061 | Lipid panel | <1% | 12 | $209.40 |
| 83540 | <1% | 24 | $131.88 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 24 | $125.83 |
| 83550 | <1% | 24 | $115.38 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $111.98 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $108.24 |
| 71045 | Radiologic examination, chest; single view | <1% | 222 | $71.55 |
| 82607 | <1% | 12 | $61.08 | |
| 85610 | <1% | 25 | $60.80 | |
| 84425 | <1% | 12 | $54.12 | |
| 81001 | <1% | 12 | $14.47 | |
| J2704 | Injection, propofol, 10 mg | <1% | 532 | $11.28 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 160 | $10.05 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 527 | $7.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,140 | $1.53 |
| 84703 | 0% | 247 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 75 | $0.00 |
| 83690 | 0% | 42 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 108 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 17 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 14 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 15 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 84 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 14 | $0.00 |
| 82077 | 0% | 18 | $0.00 | |
| 0753T | 0% | 38 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
| 81003 | 0% | 151 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAL, MATTHEW (CFO)
| Provider | Location | Paid |
|---|---|---|
| Portercare Adventist Health System | Aurora, CO | $386K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.